Skip to content

Public FDA record

Z-1577-2015: Ultraview SL Command Modules, Model 91496, with the Masimo SpO2 PCBA, PN: 010-1636-02. The Spacelabs Mu

Recall record Z-1577-2015 for Spacelabs Healthcare Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1577-2015
Company in FDA record
Spacelabs Healthcare Inc
FDA classification date
May 4, 2015
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Modules resetting. This failure mode happens when the Spacelabs Command Module is configured with the Masimo SpO2 option (-M), the Spacelabs Respiration option (-R) and the Masimo SpO2 PCBA, PN: 010-1136-02. With these two options and the Masimo SpO2 PCBA present, the module may experience random resets.

Source facts

Action
Spacelabs expanded the recall to include additional 29 units and notified one additional new consignee on June 4, 2015. ******************************************************************************************* The firm, Spacelabs Healthcare, sent an "URGENT-MEDICAL DEVICE CORRECTION" letter dated 27 April 2015, via priority mail to US consignees and email to foreign consignees. The letter described the product, problem and actions to be taken. The consignees were instructed to circulate this notification to all persons concerned by the information it contains; add a copy to the appropriated system user manuals until such time as corrections have been implemented by Spacelabs, and weigh the benefits versus the risks when deciding whether or not to continue to use your modules until they can be upgraded. Only modules shipped or repaired after March 8, 2014 are affected by this recall. Affected command modules will be upgraded with a new version of software by Spacelabs at no cost. Customer with questions about this corrective action, please contact Spacelabs Healthcare at 1-800-522-7025 and select 2 for Technical Support.
Initiated
2015-04-21
Root cause
Software design
Terminated
2015-11-16
Distribution
Worldwide Distribution:US (nationwide) including states of: AL, AR, AZ, CA, FL, GA, IA, ID, IL, LA, ME, MI, MN, MO, NE, NJ, NY, OH, OR, PA, SC, TN, TX, VA, WA, WY, and Puerto Rico and countries of: Argentina, Australia, Bangladesh, Canada, Chile, France, Great Britain, India, Kuwait, Panama, Poland, Qatar, Saudi Arabia, and Turkey. .
Recall number
Z-1577-2015
Recall status
Terminated
CDRH record ID
136155
FDA classified
2015-05-04
Recall event number
71118

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗